Related Experiment Video
Updated: Jul 16, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Complicated by Pachymeningitis: A Case Report
Sanjay M Khaladkar1, Prajakta P KirdatPatil1, Aryaman Dhande1
1Radiodiagnosis, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, IND.
Abstract:
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune disorder that primarily affects the central nervous system (CNS). We present a unique case of MOGAD complicated by pachymeningitis, which is characterized by inflammation of the dura mater. The clinical presentation included vertigo, nausea, and vomiting. A diagnostic workup confirmed MOGAD complicated by pachymeningitis. This case underscores the diverse clinical manifestations of MOGAD and highlights the challenges in diagnosis and management, particularly when complicated by rare manifestations like pachymeningitis.
Insights
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can cause rare complications like pachymeningitis, affecting the dura mater. This case highlights diagnostic challenges in MOGAD with unusual presentations.
Area of Science:
- Neurology
- Immunology
- Neuroinflammation
Background:
- Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition targeting the central nervous system (CNS).
- Pachymeningitis, inflammation of the dura mater, is an uncommon complication in neurological disorders.
Observation:
- A patient presented with symptoms including vertigo, nausea, and vomiting.
- The clinical presentation suggested a complex neurological condition.
Findings:
- Diagnostic workup confirmed MOGAD complicated by pachymeningitis.
- This indicates MOGAD can manifest with rare dural inflammation.
Implications:
- This case broadens the understanding of MOGAD's diverse clinical spectrum.
- It emphasizes the need for considering rare complications in MOGAD diagnosis and management.
More Related Videos
08:03Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
10:47Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
Published on: October 27, 2016
Related Concept Videos
Bacterial Meningitis
Poliomyelitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology